paragraph_index int64 | sec string | p_has_citation int64 | cites string | citeids list | pmid int64 | cited_id string | sentences string | all_sent_cites list | sent_len int64 | sentence_batch_index int64 | sent_has_citation float64 | qc_fail bool | cited_sentence string | cites_in_sentence list | cln_sentence string | is_cap bool | is_alpha bool | ends_wp bool | cit_qc bool | lgtm bool | __index_level_0__ int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | INTRODUCTION | 1 | 2 | [
"R1",
"R2"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | Staining of slides by Ziehl-Neelsen (ZN) methods for AFB diagnosis remain the main procedure utilized in these countries, while fluorescent microscopy has been used in developed countries for decades in the identification of M. tuberculosis in clinical specimens [2]. | [
"1",
"2"
] | 267 | 39,816 | 1 | false | Staining of slides by Ziehl-Neelsen (ZN) methods for AFB diagnosis remain the main procedure utilized in these countries, while fluorescent microscopy has been used in developed countries for decades in the identification of M. tuberculosis in clinical specimens. | [
"2"
] | Staining of slides by Ziehl-Neelsen (ZN) methods for AFB diagnosis remain the main procedure utilized in these countries, while fluorescent microscopy has been used in developed countries for decades in the identification of M. tuberculosis in clinical specimens. | true | true | true | true | true | 6,882 |
0 | INTRODUCTION | 1 | 1 | [
"R1",
"R2"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | Acid fast staining and microscopy is technically challenging and labor intensive. | [
"1",
"2"
] | 81 | 39,817 | 0 | false | Acid fast staining and microscopy is technically challenging and labor intensive. | [] | Acid fast staining and microscopy is technically challenging and labor intensive. | true | true | true | true | true | 6,882 |
0 | INTRODUCTION | 1 | 1 | [
"R1",
"R2"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | Culture techniques, the gold standard for tuberculosis diagnosis, are also expensive, technically difficult and generally not available in developing countries. | [
"1",
"2"
] | 160 | 39,818 | 0 | false | Culture techniques, the gold standard for tuberculosis diagnosis, are also expensive, technically difficult and generally not available in developing countries. | [] | Culture techniques, the gold standard for tuberculosis diagnosis, are also expensive, technically difficult and generally not available in developing countries. | true | true | true | true | true | 6,882 |
0 | INTRODUCTION | 1 | 1 | [
"R1",
"R2"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | Fluorescent microscopy of sputum smears is an alternative to traditional AFB (acid fast bacilli) staining and light microscopy. | [
"1",
"2"
] | 127 | 39,819 | 0 | false | Fluorescent microscopy of sputum smears is an alternative to traditional AFB (acid fast bacilli) staining and light microscopy. | [] | Fluorescent microscopy of sputum smears is an alternative to traditional AFB (acid fast bacilli) staining and light microscopy. | true | true | true | true | true | 6,882 |
0 | INTRODUCTION | 1 | 1 | [
"R1",
"R2"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | A portable LED (light-emitting diode) fluorescent adaptor, called ParaLens™ (QBC Diagnostic Inc., Port Matilda, PA), allows a traditional light microscope to utilize fluorescent technology. | [
"1",
"2"
] | 189 | 39,820 | 0 | false | A portable LED (light-emitting diode) fluorescent adaptor, called ParaLens™ (QBC Diagnostic Inc., Port Matilda, PA), allows a traditional light microscope to utilize fluorescent technology. | [] | A portable LED (light-emitting diode) fluorescent adaptor, called ParaLens™ (QBC Diagnostic Inc., Port Matilda, PA), allows a traditional light microscope to utilize fluorescent technology. | true | true | true | true | true | 6,882 |
0 | INTRODUCTION | 1 | 1 | [
"R1",
"R2"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | However, little is known about the functionality of LED-based systems for AFB fluorescent microscopy in the developing world. | [
"1",
"2"
] | 125 | 39,821 | 0 | false | However, little is known about the functionality of LED-based systems for AFB fluorescent microscopy in the developing world. | [] | However, little is known about the functionality of LED-based systems for AFB fluorescent microscopy in the developing world. | true | true | true | true | true | 6,882 |
0 | INTRODUCTION | 1 | 1 | [
"R1",
"R2"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | Therefore the purpose of this study was to test this ParaLens system (an updated version from a previous non-QBC based attachment) and thus fluorescent microscopy in various urban and rural resource poor settings lacking conventional laboratory facilities to determine its usefulness in these environments. | [
"1",
"2"
] | 306 | 39,822 | 0 | false | Therefore the purpose of this study was to test this ParaLens system (an updated version from a previous non-QBC based attachment) and thus fluorescent microscopy in various urban and rural resource poor settings lacking conventional laboratory facilities to determine its usefulness in these environments. | [] | Therefore the purpose of this study was to test this ParaLens system (an updated version from a previous non-QBC based attachment) and thus fluorescent microscopy in various urban and rural resource poor settings lacking conventional laboratory facilities to determine its usefulness in these environments. | true | true | true | true | true | 6,882 |
0 | INTRODUCTION | 1 | 1 | [
"R1",
"R2"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | The authors also compared the accuracy of the ParaLens versus a traditional fluorescent microscope in a controlled setting for the diagnosis of mycobacterial disease in a public health laboratory in the United States. | [
"1",
"2"
] | 217 | 39,823 | 0 | false | The authors also compared the accuracy of the ParaLens versus a traditional fluorescent microscope in a controlled setting for the diagnosis of mycobacterial disease in a public health laboratory in the United States. | [] | The authors also compared the accuracy of the ParaLens versus a traditional fluorescent microscope in a controlled setting for the diagnosis of mycobacterial disease in a public health laboratory in the United States. | true | true | true | true | true | 6,882 |
0 | DISCUSSION | 1 | 1 | [
"R1",
"R5",
"R5",
"R6"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | Tuberculosis is a leading cause of morbidity and mortality worldwide, especially in resource-limited settings [1, 5]. | [
"1",
" 5",
"5",
"6"
] | 117 | 39,824 | 0 | false | Tuberculosis is a leading cause of morbidity and mortality worldwide, especially in resource-limited settings. | [
"1, 5"
] | Tuberculosis is a leading cause of morbidity and mortality worldwide, especially in resource-limited settings. | true | true | true | true | true | 6,883 |
0 | DISCUSSION | 1 | 1 | [
"R1",
"R5",
"R5",
"R6"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | The WHO has made the recognition and treatment of patients with tuberculosis one of its highest priorities. | [
"1",
" 5",
"5",
"6"
] | 107 | 39,825 | 0 | false | The WHO has made the recognition and treatment of patients with tuberculosis one of its highest priorities. | [] | The WHO has made the recognition and treatment of patients with tuberculosis one of its highest priorities. | true | true | true | true | true | 6,883 |
0 | DISCUSSION | 1 | 1 | [
"R1",
"R5",
"R5",
"R6"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | Research and development of improved diagnostics is one of the main goals set in The Global Plan to Stop TB 2006-2015 (WHO) | [
"1",
" 5",
"5",
"6"
] | 123 | 39,826 | 0 | false | Research and development of improved diagnostics is one of the main goals set in The Global Plan to Stop TB 2006-2015 (WHO) | [] | Research and development of improved diagnostics is one of the main goals set in The Global Plan to Stop TB 2006-2015 (WHO) | true | true | false | true | false | 6,883 |
0 | DISCUSSION | 1 | 6 | [
"R1",
"R5",
"R5",
"R6"
] | 20,556,200 | NA|pmid-17624822|NA|NA|NA|pmid-16055883 | To meet these needs, diagnostic tools must be made more adequate than currently utilized methods and must also be safe, affordable and easy to use [6]. | [
"1",
" 5",
"5",
"6"
] | 151 | 39,827 | 1 | false | To meet these needs, diagnostic tools must be made more adequate than currently utilized methods and must also be safe, affordable and easy to use. | [
"6"
] | To meet these needs, diagnostic tools must be made more adequate than currently utilized methods and must also be safe, affordable and easy to use. | true | true | true | true | true | 6,883 |
1 | DISCUSSION | 1 | 7 | [
"R7"
] | 20,556,200 | pmid-9542935 | Fluorescent microscopy methods for the identification of acid-fast organisms have become the mainstay of many mycobacteriological laboratories in the United States and around the world [7]. | [
"7"
] | 189 | 39,828 | 1 | false | Fluorescent microscopy methods for the identification of acid-fast organisms have become the mainstay of many mycobacteriological laboratories in the United States and around the world. | [
"7"
] | Fluorescent microscopy methods for the identification of acid-fast organisms have become the mainstay of many mycobacteriological laboratories in the United States and around the world. | true | true | true | true | true | 6,884 |
1 | DISCUSSION | 1 | 7 | [
"R7"
] | 20,556,200 | pmid-9542935 | In standard acid-fast microscopy, the oil immersion lens is used to scan the slide (1000x magnification) while in fluorescent microscopy, lesser magnification is used, thus saving a significant amount of time on each negative slide. | [
"7"
] | 232 | 39,829 | 0 | false | In standard acid-fast microscopy, the oil immersion lens is used to scan the slide (1000x magnification) while in fluorescent microscopy, lesser magnification is used, thus saving a significant amount of time on each negative slide. | [] | In standard acid-fast microscopy, the oil immersion lens is used to scan the slide (1000x magnification) while in fluorescent microscopy, lesser magnification is used, thus saving a significant amount of time on each negative slide. | true | true | true | true | true | 6,884 |
1 | DISCUSSION | 1 | 7 | [
"R7"
] | 20,556,200 | pmid-9542935 | Fluorescent microscopy is preferred in healthcare settings with large numbers of specimens submitted for suspected mycobacterial disease. | [
"7"
] | 137 | 39,830 | 0 | false | Fluorescent microscopy is preferred in healthcare settings with large numbers of specimens submitted for suspected mycobacterial disease. | [] | Fluorescent microscopy is preferred in healthcare settings with large numbers of specimens submitted for suspected mycobacterial disease. | true | true | true | true | true | 6,884 |
2 | DISCUSSION | 1 | 8 | [
"R8",
"R9",
"R6",
"R10",
"R12"
] | 20,556,200 | pmid-17620757|pmid-18405928|pmid-16055883|pmid-16931408|pmid-18532893 | The use of improved diagnostics including fluorescent microscopy (such as the ParaLens system) in developing nations has been limited by lack of infrastructure, trained laboratory staff and lack of funding [8, 9]. | [
"8",
" 9",
"6",
" 10",
"12"
] | 213 | 39,831 | 0 | false | The use of improved diagnostics including fluorescent microscopy (such as the ParaLens system) in developing nations has been limited by lack of infrastructure, trained laboratory staff and lack of funding. | [
"8, 9"
] | The use of improved diagnostics including fluorescent microscopy (such as the ParaLens system) in developing nations has been limited by lack of infrastructure, trained laboratory staff and lack of funding. | true | true | true | true | true | 6,885 |
2 | DISCUSSION | 1 | 8 | [
"R8",
"R9",
"R6",
"R10",
"R12"
] | 20,556,200 | pmid-17620757|pmid-18405928|pmid-16055883|pmid-16931408|pmid-18532893 | However, fluorescent microscopy is potentially more sensitive and less labor intensive than traditional light microscopy using the Ziehl-Neelsen or Kinyoun method for the identification of acid-fast bacilli | [
"8",
" 9",
"6",
" 10",
"12"
] | 206 | 39,832 | 0 | false | However, fluorescent microscopy is potentially more sensitive and less labor intensive than traditional light microscopy using the Ziehl-Neelsen or Kinyoun method for the identification of acid-fast bacilli | [] | However, fluorescent microscopy is potentially more sensitive and less labor intensive than traditional light microscopy using the Ziehl-Neelsen or Kinyoun method for the identification of acid-fast bacilli | true | true | false | true | false | 6,885 |
2 | DISCUSSION | 1 | 8 | [
"R8",
"R9",
"R6",
"R10",
"R12"
] | 20,556,200 | pmid-17620757|pmid-18405928|pmid-16055883|pmid-16931408|pmid-18532893 | [6, 10-12]. | [
"8",
" 9",
"6",
" 10",
"12"
] | 11 | 39,833 | 0 | false | . | [
"6, 10-12"
] | . | false | false | true | true | false | 6,885 |
2 | DISCUSSION | 1 | 8 | [
"R8",
"R9",
"R6",
"R10",
"R12"
] | 20,556,200 | pmid-17620757|pmid-18405928|pmid-16055883|pmid-16931408|pmid-18532893 | Thus microscopists trained using conventional fluorescent staining and dark-field microscopy will have no problem reading slides with the ParaLens, as the technology is virtually the same. | [
"8",
" 9",
"6",
" 10",
"12"
] | 188 | 39,834 | 0 | false | Thus microscopists trained using conventional fluorescent staining and dark-field microscopy will have no problem reading slides with the ParaLens, as the technology is virtually the same. | [] | Thus microscopists trained using conventional fluorescent staining and dark-field microscopy will have no problem reading slides with the ParaLens, as the technology is virtually the same. | true | true | true | true | true | 6,885 |
3 | DISCUSSION | 1 | 13 | [
"R13",
"R14",
"R12",
"R15"
] | 20,556,200 | pmid-7535314|pmid-8458971|pmid-18532893|pmid-16546544 | Therefore the ParaLens system is uniquely suited for application in developing countries. | [
"13",
" 14",
"12",
"15"
] | 89 | 39,835 | 0 | false | Therefore the ParaLens system is uniquely suited for application in developing countries. | [] | Therefore the ParaLens system is uniquely suited for application in developing countries. | true | true | true | true | true | 6,886 |
3 | DISCUSSION | 1 | 13 | [
"R13",
"R14",
"R12",
"R15"
] | 20,556,200 | pmid-7535314|pmid-8458971|pmid-18532893|pmid-16546544 | Lower costs than traditional fluorescent scopes provides affordability, and as demonstrated in this study, it is functional, durable, accurate and easy to use in rural, resource poor field environments and with various power options. | [
"13",
" 14",
"12",
"15"
] | 233 | 39,836 | 0 | false | Lower costs than traditional fluorescent scopes provides affordability, and as demonstrated in this study, it is functional, durable, accurate and easy to use in rural, resource poor field environments and with various power options. | [] | Lower costs than traditional fluorescent scopes provides affordability, and as demonstrated in this study, it is functional, durable, accurate and easy to use in rural, resource poor field environments and with various power options. | true | true | true | true | true | 6,886 |
3 | DISCUSSION | 1 | 13 | [
"R13",
"R14",
"R12",
"R15"
] | 20,556,200 | pmid-7535314|pmid-8458971|pmid-18532893|pmid-16546544 | The attachment avoids the purchase of a second microscope, since it utilizes an already existing compound microscope. | [
"13",
" 14",
"12",
"15"
] | 117 | 39,837 | 0 | false | The attachment avoids the purchase of a second microscope, since it utilizes an already existing compound microscope. | [] | The attachment avoids the purchase of a second microscope, since it utilizes an already existing compound microscope. | true | true | true | true | true | 6,886 |
3 | DISCUSSION | 1 | 13 | [
"R13",
"R14",
"R12",
"R15"
] | 20,556,200 | pmid-7535314|pmid-8458971|pmid-18532893|pmid-16546544 | Previous studies have tested a non-QBC ParaLens system utilizing a halogen bulb and fiber-optic cable, which limited the bulb life and luminosity [13, 14]. | [
"13",
" 14",
"12",
"15"
] | 155 | 39,838 | 0 | false | Previous studies have tested a non-QBC ParaLens system utilizing a halogen bulb and fiber-optic cable, which limited the bulb life and luminosity. | [
"13, 14"
] | Previous studies have tested a non-QBC ParaLens system utilizing a halogen bulb and fiber-optic cable, which limited the bulb life and luminosity. | true | true | true | true | true | 6,886 |
3 | DISCUSSION | 1 | 13 | [
"R13",
"R14",
"R12",
"R15"
] | 20,556,200 | pmid-7535314|pmid-8458971|pmid-18532893|pmid-16546544 | The use of LED bulbs in place of standard fluorescent bulbs provides extended life (estimated to be 15-30,000 hours), much longer compared to the life of a standard bulb (estimated 800 hours). | [
"13",
" 14",
"12",
"15"
] | 192 | 39,839 | 0 | false | The use of LED bulbs in place of standard fluorescent bulbs provides extended life, much longer compared to the life of a standard bulb (estimated 800 hours). | [
"estimated to be 15-30,000 hours"
] | The use of LED bulbs in place of standard fluorescent bulbs provides extended life, much longer compared to the life of a standard bulb (estimated 800 hours). | true | true | true | true | true | 6,886 |
3 | DISCUSSION | 1 | 13 | [
"R13",
"R14",
"R12",
"R15"
] | 20,556,200 | pmid-7535314|pmid-8458971|pmid-18532893|pmid-16546544 | The attachment can be used with standard 110V electricity, 220V electricity and with a battery for locations without electricity. | [
"13",
" 14",
"12",
"15"
] | 129 | 39,840 | 0 | false | The attachment can be used with standard 110V electricity, 220V electricity and with a battery for locations without electricity. | [] | The attachment can be used with standard 110V electricity, 220V electricity and with a battery for locations without electricity. | true | true | true | true | true | 6,886 |
3 | DISCUSSION | 1 | 13 | [
"R13",
"R14",
"R12",
"R15"
] | 20,556,200 | pmid-7535314|pmid-8458971|pmid-18532893|pmid-16546544 | The attachment compared favorably with more expensive conventional fluorescent microscopes in brightness, clarity and ease of viewing (see Figs. | [
"13",
" 14",
"12",
"15"
] | 144 | 39,841 | 0 | false | The attachment compared favorably with more expensive conventional fluorescent microscopes in brightness, clarity and ease of viewing (see Figs. | [] | The attachment compared favorably with more expensive conventional fluorescent microscopes in brightness, clarity and ease of viewing (see Figs. | true | true | true | true | true | 6,886 |
3 | DISCUSSION | 1 | 13 | [
"R13",
"R14",
"R12",
"R15"
] | 20,556,200 | pmid-7535314|pmid-8458971|pmid-18532893|pmid-16546544 | Other authors have also found that the use of such equipment can indeed provide an excellent tool for identification of mycobacteria and can be a useful alternative to conventional fluorescent microscopy | [
"13",
" 14",
"12",
"15"
] | 203 | 39,842 | 0 | false | Other authors have also found that the use of such equipment can indeed provide an excellent tool for identification of mycobacteria and can be a useful alternative to conventional fluorescent microscopy | [] | Other authors have also found that the use of such equipment can indeed provide an excellent tool for identification of mycobacteria and can be a useful alternative to conventional fluorescent microscopy | true | true | false | true | false | 6,886 |
4 | DISCUSSION | 0 | null | null | 20,556,200 | null | One limitation of this study was that the results were based on known positive and negative control slides prepared in the United States. | null | 137 | 39,843 | 0 | false | null | null | One limitation of this study was that the results were based on known positive and negative control slides prepared in the United States. | true | true | true | true | true | 6,887 |
4 | DISCUSSION | 0 | null | null | 20,556,200 | null | While this does not affect the durability portion of the study, it is possible that sputum samples collected from patients outside the controlled setting of a public health laboratory in the United States under field conditions in the developing world may stain differently. | null | 274 | 39,844 | 0 | false | null | null | While this does not affect the durability portion of the study, it is possible that sputum samples collected from patients outside the controlled setting of a public health laboratory in the United States under field conditions in the developing world may stain differently. | true | true | true | true | true | 6,887 |
0 | DISCUSSION | 1 | 52 | [
"bib52",
"bib53"
] | 17,646,409 | pmid-10221902|pmid-17168741 | The early successes of molecularly targeted therapy, such as imatinib mesylate directed against the BCR-ABL fusion protein in chronic myelogenous leukemia, stimulated enormous interest in subverting abnormal signaling pathways in cancer cells. | [
"52",
"53"
] | 243 | 39,845 | 0 | false | The early successes of molecularly targeted therapy, such as imatinib mesylate directed against the BCR-ABL fusion protein in chronic myelogenous leukemia, stimulated enormous interest in subverting abnormal signaling pathways in cancer cells. | [] | The early successes of molecularly targeted therapy, such as imatinib mesylate directed against the BCR-ABL fusion protein in chronic myelogenous leukemia, stimulated enormous interest in subverting abnormal signaling pathways in cancer cells. | true | true | true | true | true | 6,888 |
0 | DISCUSSION | 1 | 52 | [
"bib52",
"bib53"
] | 17,646,409 | pmid-10221902|pmid-17168741 | The NOTCH signaling cascade influences normal development by regulating differentiation, proliferation, and apoptosis (52). | [
"52",
"53"
] | 123 | 39,846 | 1 | false | The NOTCH signaling cascade influences normal development by regulating differentiation, proliferation, and apoptosis. | [
"52"
] | The NOTCH signaling cascade influences normal development by regulating differentiation, proliferation, and apoptosis. | true | true | true | true | true | 6,888 |
0 | DISCUSSION | 1 | 53 | [
"bib52",
"bib53"
] | 17,646,409 | pmid-10221902|pmid-17168741 | Activation of the NOTCH signaling pathway is firmly established in T-ALL and is likely involved in the genesis of many other tumor types (53). | [
"52",
"53"
] | 142 | 39,847 | 1 | false | Activation of the NOTCH signaling pathway is firmly established in T-ALL and is likely involved in the genesis of many other tumor types. | [
"53"
] | Activation of the NOTCH signaling pathway is firmly established in T-ALL and is likely involved in the genesis of many other tumor types. | true | true | true | true | true | 6,888 |
0 | DISCUSSION | 1 | 52 | [
"bib52",
"bib53"
] | 17,646,409 | pmid-10221902|pmid-17168741 | Thus, it is not surprising that efforts to block NOTCH signaling as a novel therapeutic strategy are under way in T-ALL as well as in solid tumors. | [
"52",
"53"
] | 147 | 39,848 | 0 | false | Thus, it is not surprising that efforts to block NOTCH signaling as a novel therapeutic strategy are under way in T-ALL as well as in solid tumors. | [] | Thus, it is not surprising that efforts to block NOTCH signaling as a novel therapeutic strategy are under way in T-ALL as well as in solid tumors. | true | true | true | true | true | 6,888 |
0 | DISCUSSION | 1 | 52 | [
"bib52",
"bib53"
] | 17,646,409 | pmid-10221902|pmid-17168741 | One of the most promising approaches has been to inhibit NOTCH receptor signaling using GSIs. | [
"52",
"53"
] | 93 | 39,849 | 0 | false | One of the most promising approaches has been to inhibit NOTCH receptor signaling using GSIs. | [] | One of the most promising approaches has been to inhibit NOTCH receptor signaling using GSIs. | true | true | true | true | true | 6,888 |
0 | DISCUSSION | 1 | 52 | [
"bib52",
"bib53"
] | 17,646,409 | pmid-10221902|pmid-17168741 | This strategy suppresses the generation of NICD and thus, in principle, should inhibit the downstream transcriptional events normally induced by this key signaling component after it traverses to the nucleus. | [
"52",
"53"
] | 208 | 39,850 | 0 | false | This strategy suppresses the generation of NICD and thus, in principle, should inhibit the downstream transcriptional events normally induced by this key signaling component after it traverses to the nucleus. | [] | This strategy suppresses the generation of NICD and thus, in principle, should inhibit the downstream transcriptional events normally induced by this key signaling component after it traverses to the nucleus. | true | true | true | true | true | 6,888 |
0 | DISCUSSION | 1 | 52 | [
"bib52",
"bib53"
] | 17,646,409 | pmid-10221902|pmid-17168741 | Although effective against some T-ALL cell lines, GSIs do not uniformly eliminate leukemic cells with activated NOTCH signaling. | [
"52",
"53"
] | 128 | 39,851 | 0 | false | Although effective against some T-ALL cell lines, GSIs do not uniformly eliminate leukemic cells with activated NOTCH signaling. | [] | Although effective against some T-ALL cell lines, GSIs do not uniformly eliminate leukemic cells with activated NOTCH signaling. | true | true | true | true | true | 6,888 |
0 | DISCUSSION | 1 | 52 | [
"bib52",
"bib53"
] | 17,646,409 | pmid-10221902|pmid-17168741 | Understanding the mechanisms of GSI resistance may lead to better treatments for T-ALL. | [
"52",
"53"
] | 87 | 39,852 | 0 | false | Understanding the mechanisms of GSI resistance may lead to better treatments for T-ALL. | [] | Understanding the mechanisms of GSI resistance may lead to better treatments for T-ALL. | true | true | true | true | true | 6,888 |
1 | DISCUSSION | 0 | null | null | 17,646,409 | null | We found missense FBW7 mutations or homozygous FBW7 deletion in GSI-resistant T-ALL cell lines and in primary T-ALL samples. | null | 124 | 39,853 | 0 | false | null | null | We found missense FBW7 mutations or homozygous FBW7 deletion in GSI-resistant T-ALL cell lines and in primary T-ALL samples. | true | true | true | true | true | 6,889 |
1 | DISCUSSION | 0 | null | null | 17,646,409 | null | Moreover, we have defined the NOTCH phosphodegron and demonstrated that the mutant forms of FBW7 found in T-ALL cannot bind to the NICD. | null | 136 | 39,854 | 0 | false | null | null | Moreover, we have defined the NOTCH phosphodegron and demonstrated that the mutant forms of FBW7 found in T-ALL cannot bind to the NICD. | true | true | true | true | true | 6,889 |
1 | DISCUSSION | 0 | null | null | 17,646,409 | null | Each T-ALL cell line with constitutive NICD expression harbored either NOTCH1 PEST domain or FBW7 mutations, suggesting that these two classes of mutations provide a mutually exclusive means of prolonging the NICD half-life. | null | 224 | 39,855 | 0 | false | null | null | Each T-ALL cell line with constitutive NICD expression harbored either NOTCH1 PEST domain or FBW7 mutations, suggesting that these two classes of mutations provide a mutually exclusive means of prolonging the NICD half-life. | true | true | true | true | true | 6,889 |
1 | DISCUSSION | 0 | null | null | 17,646,409 | null | We also show that the expression of NOTCH target genes including DELTEX1 and MYC are not affected by GSI treatment in five resistant T-ALL cell lines with mutations in FBW7 (CEM, BE13, PEER, DU528, and HSB2), demonstrating that the mechanism of resistance in these leukemias lies upstream of MYC and DELTEX1 transcriptio... | null | 322 | 39,856 | 0 | false | null | null | We also show that the expression of NOTCH target genes including DELTEX1 and MYC are not affected by GSI treatment in five resistant T-ALL cell lines with mutations in FBW7 (CEM, BE13, PEER, DU528, and HSB2), demonstrating that the mechanism of resistance in these leukemias lies upstream of MYC and DELTEX1 transcriptio... | true | true | true | true | true | 6,889 |
1 | DISCUSSION | 0 | null | null | 17,646,409 | null | It appears that in these T-ALL lines, one consequence of FBW7 mutation is stabilization of the NICD resulting in sustained NOTCH signaling, and thus promoting resistance to GSIs. | null | 178 | 39,857 | 0 | false | null | null | It appears that in these T-ALL lines, one consequence of FBW7 mutation is stabilization of the NICD resulting in sustained NOTCH signaling, and thus promoting resistance to GSIs. | true | true | true | true | true | 6,889 |
1 | DISCUSSION | 0 | null | null | 17,646,409 | null | However, other FBW7 substrates, such as MYC, may also account for selection for FBW7 mutations and for GSI resistance in T-ALL, as suggested by our finding that ALL-associated FBW7 mutations can dominantly inhibit MYC degradation. | null | 230 | 39,858 | 0 | false | null | null | However, other FBW7 substrates, such as MYC, may also account for selection for FBW7 mutations and for GSI resistance in T-ALL, as suggested by our finding that ALL-associated FBW7 mutations can dominantly inhibit MYC degradation. | true | true | true | true | true | 6,889 |
2 | DISCUSSION | 0 | null | null | 17,646,409 | null | An important question is why FBW7 mutation confers GSI resistance, whereas NOTCH PEST domain truncations that remove the FBW7 interaction domain do not. | null | 152 | 39,859 | 0 | false | null | null | An important question is why FBW7 mutation confers GSI resistance, whereas NOTCH PEST domain truncations that remove the FBW7 interaction domain do not. | true | true | true | true | true | 6,890 |
2 | DISCUSSION | 0 | null | null | 17,646,409 | null | In each cell line with PEST mutations, only one allele is affected by these heterozygous mutations, leaving the remaining normal allele, which encodes an NICD that is stabilized in the presence of mutant FBW7. | null | 209 | 39,860 | 0 | false | null | null | In each cell line with PEST mutations, only one allele is affected by these heterozygous mutations, leaving the remaining normal allele, which encodes an NICD that is stabilized in the presence of mutant FBW7. | true | true | true | true | true | 6,890 |
2 | DISCUSSION | 0 | null | null | 17,646,409 | null | Thus, although the amount of increased NOTCH activity resulting from the single allele PEST mutations may be sufficient to underlie the primary selection for these mutations, disruption of FBW7 function may be more active in sustaining NOTCH signaling and also may prolong the half-life of MYC (as well as other substrat... | null | 360 | 39,861 | 0 | false | null | null | Thus, although the amount of increased NOTCH activity resulting from the single allele PEST mutations may be sufficient to underlie the primary selection for these mutations, disruption of FBW7 function may be more active in sustaining NOTCH signaling and also may prolong the half-life of MYC (as well as other substrat... | true | true | true | true | true | 6,890 |
3 | DISCUSSION | 1 | 5 | [
"bib5",
"bib54"
] | 17,646,409 | pmid-16751266|pmid-12479216 | The association between FBW7 mutations and resistance to GSIs has implications for clinical testing of these agents in patients whose cancers show deregulation of the NOTCH pathway. | [
"5",
"54"
] | 181 | 39,862 | 0 | false | The association between FBW7 mutations and resistance to GSIs has implications for clinical testing of these agents in patients whose cancers show deregulation of the NOTCH pathway. | [] | The association between FBW7 mutations and resistance to GSIs has implications for clinical testing of these agents in patients whose cancers show deregulation of the NOTCH pathway. | true | true | true | true | true | 6,891 |
3 | DISCUSSION | 1 | 5 | [
"bib5",
"bib54"
] | 17,646,409 | pmid-16751266|pmid-12479216 | Molecular analysis of the FBW7 gene, as well as genes encoding the relevant NOTCH receptors and other key components of the NOTCH signaling pathway, such as NUMB, may contribute to identification of patients likely to be most responsive to GSI therapy. | [
"5",
"54"
] | 252 | 39,863 | 0 | false | Molecular analysis of the FBW7 gene, as well as genes encoding the relevant NOTCH receptors and other key components of the NOTCH signaling pathway, such as NUMB, may contribute to identification of patients likely to be most responsive to GSI therapy. | [] | Molecular analysis of the FBW7 gene, as well as genes encoding the relevant NOTCH receptors and other key components of the NOTCH signaling pathway, such as NUMB, may contribute to identification of patients likely to be most responsive to GSI therapy. | true | true | true | true | true | 6,891 |
3 | DISCUSSION | 1 | 5 | [
"bib5",
"bib54"
] | 17,646,409 | pmid-16751266|pmid-12479216 | Because Myc has recently been shown to be an important target of Notch in mammary tumorigenesis as well as in T-ALL (5), it might also be possible to overcome GSI resistance by combining GSIs with other drugs that block the MYC pathway to synergistically reduce MYC levels and block tumor cell growth. | [
"5",
"54"
] | 301 | 39,864 | 1 | false | Because Myc has recently been shown to be an important target of Notch in mammary tumorigenesis as well as in T-ALL, it might also be possible to overcome GSI resistance by combining GSIs with other drugs that block the MYC pathway to synergistically reduce MYC levels and block tumor cell growth. | [
"5"
] | Because Myc has recently been shown to be an important target of Notch in mammary tumorigenesis as well as in T-ALL, it might also be possible to overcome GSI resistance by combining GSIs with other drugs that block the MYC pathway to synergistically reduce MYC levels and block tumor cell growth. | true | true | true | true | true | 6,891 |
3 | DISCUSSION | 1 | 5 | [
"bib5",
"bib54"
] | 17,646,409 | pmid-16751266|pmid-12479216 | One attractive candidate is TMPyP4, a cationic porphyrin that binds to and stabilizes guanine quadruplexes in DNA. | [
"5",
"54"
] | 114 | 39,865 | 0 | false | One attractive candidate is TMPyP4, a cationic porphyrin that binds to and stabilizes guanine quadruplexes in DNA. | [] | One attractive candidate is TMPyP4, a cationic porphyrin that binds to and stabilizes guanine quadruplexes in DNA. | true | true | true | true | true | 6,891 |
3 | DISCUSSION | 1 | 54 | [
"bib5",
"bib54"
] | 17,646,409 | pmid-16751266|pmid-12479216 | MYC contains a sequence in its promoter that forms a guanine quadruplex, and TMPyP4 has been shown to inhibit MYC transcription and the growth of tumor cells in vivo (54). | [
"5",
"54"
] | 171 | 39,866 | 1 | false | MYC contains a sequence in its promoter that forms a guanine quadruplex, and TMPyP4 has been shown to inhibit MYC transcription and the growth of tumor cells in vivo. | [
"54"
] | MYC contains a sequence in its promoter that forms a guanine quadruplex, and TMPyP4 has been shown to inhibit MYC transcription and the growth of tumor cells in vivo. | true | true | true | true | true | 6,891 |
3 | DISCUSSION | 1 | 5 | [
"bib5",
"bib54"
] | 17,646,409 | pmid-16751266|pmid-12479216 | Thus, TMPyP4 or other agents that inhibit MYC transcription may be useful in combination with GSIs to overcome resistance in patients harboring FBW7 mutations. | [
"5",
"54"
] | 159 | 39,867 | 0 | false | Thus, TMPyP4 or other agents that inhibit MYC transcription may be useful in combination with GSIs to overcome resistance in patients harboring FBW7 mutations. | [] | Thus, TMPyP4 or other agents that inhibit MYC transcription may be useful in combination with GSIs to overcome resistance in patients harboring FBW7 mutations. | true | true | true | true | true | 6,891 |
3 | DISCUSSION | 1 | 5 | [
"bib5",
"bib54"
] | 17,646,409 | pmid-16751266|pmid-12479216 | Pharmacologic or genetic strategies that restore the normal function of FBW7 in tumor cells could also be therapeutically useful. | [
"5",
"54"
] | 129 | 39,868 | 0 | false | Pharmacologic or genetic strategies that restore the normal function of FBW7 in tumor cells could also be therapeutically useful. | [] | Pharmacologic or genetic strategies that restore the normal function of FBW7 in tumor cells could also be therapeutically useful. | true | true | true | true | true | 6,891 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | The crystal structure of p35 C285A depicts one possible arrangement of the
intact polypeptide chains in procaspase-1 dimers at very high concentrations. | [
"21",
"43",
"42",
"44",
"45"
] | 153 | 39,869 | 0 | false | The crystal structure of p35 C285A depicts one possible arrangement of the intact polypeptide chains in procaspase-1 dimers at very high concentrations. | [] | The crystal structure of p35 C285A depicts one possible arrangement of the intact polypeptide chains in procaspase-1 dimers at very high concentrations. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | This arrangement is likely similar to what occurs during oligomerization on
inflammasomes and lends support for a mechanism of activation that occurs
through intradimer cleavage. | [
"21",
"43",
"42",
"44",
"45"
] | 180 | 39,870 | 0 | false | This arrangement is likely similar to what occurs during oligomerization on inflammasomes and lends support for a mechanism of activation that occurs through intradimer cleavage. | [] | This arrangement is likely similar to what occurs during oligomerization on inflammasomes and lends support for a mechanism of activation that occurs through intradimer cleavage. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | This is observed in the C-terminal region of the
large subunit, which is positioned along the dimer interface in a cavity that
is normally unoccupied in the ligand-free form of the enzyme
(Fig. | [
"21",
"43",
"42",
"44",
"45"
] | 196 | 39,871 | 0 | false | This is observed in the C-terminal region of the large subunit, which is positioned along the dimer interface in a cavity that is normally unoccupied in the ligand-free form of the enzyme (Fig. | [] | This is observed in the C-terminal region of the large subunit, which is positioned along the dimer interface in a cavity that is normally unoccupied in the ligand-free form of the enzyme (Fig. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | 3, A and
B) (21,
43). | [
"21",
"43",
"42",
"44",
"45"
] | 23 | 39,872 | 0 | false | 3, A and B). | [
"21,\n 43"
] | 3, A and B). | false | false | true | true | false | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | The peptide chain
undergoes a sharp turn at Gly287, continues for 10 amino acids down
the dimer interface, and ends with Asp297 positioned very close to
the catalytic residue of the neighboring enzyme
(Fig. | [
"21",
"43",
"42",
"44",
"45"
] | 210 | 39,873 | 0 | false | The peptide chain undergoes a sharp turn at Gly287, continues for 10 amino acids down the dimer interface, and ends with Asp297 positioned very close to the catalytic residue of the neighboring enzyme (Fig. | [] | The peptide chain undergoes a sharp turn at Gly287, continues for 10 amino acids down the dimer interface, and ends with Asp297 positioned very close to the catalytic residue of the neighboring enzyme (Fig. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | This
position is close enough to the catalytic site to allow cleavage of the
peptide bond following Asp297. | [
"21",
"43",
"42",
"44",
"45"
] | 109 | 39,874 | 0 | false | This position is close enough to the catalytic site to allow cleavage of the peptide bond following Asp297. | [] | This position is close enough to the catalytic site to allow cleavage of the peptide bond following Asp297. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | Normally, the aspartic acid side
chain of substrate is bound in a positively charged pocket containing
Arg179 and Arg341, but this pocket is not formed in the
zymogen structure because the putative substrate is positioned on the opposite
side of the catalytic cysteine. | [
"21",
"43",
"42",
"44",
"45"
] | 273 | 39,875 | 0 | false | Normally, the aspartic acid side chain of substrate is bound in a positively charged pocket containing Arg179 and Arg341, but this pocket is not formed in the zymogen structure because the putative substrate is positioned on the opposite side of the catalytic cysteine. | [] | Normally, the aspartic acid side chain of substrate is bound in a positively charged pocket containing Arg179 and Arg341, but this pocket is not formed in the zymogen structure because the putative substrate is positioned on the opposite side of the catalytic cysteine. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 42 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | For proteolysis to occur here, only the
catalytic cysteine needs to reposition for hydrolysis because activity is not
absolutely dependent on the other member of the catalytic dyad,
His237 (42). | [
"21",
"43",
"42",
"44",
"45"
] | 197 | 39,876 | 1 | false | For proteolysis to occur here, only the catalytic cysteine needs to reposition for hydrolysis because activity is not absolutely dependent on the other member of the catalytic dyad, His237. | [
"42"
] | For proteolysis to occur here, only the catalytic cysteine needs to reposition for hydrolysis because activity is not absolutely dependent on the other member of the catalytic dyad, His237. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | The
carbonyl oxygen of Asp297, however, is within 3.5 Å of the
amide nitrogen of Arg240 and near the side chains of
Arg240 and Arg286, which could stabilize a negatively
charged transition state and behave like an oxyanion hole. | [
"21",
"43",
"42",
"44",
"45"
] | 232 | 39,877 | 0 | false | The carbonyl oxygen of Asp297, however, is within 3.5 Å of the amide nitrogen of Arg240 and near the side chains of Arg240 and Arg286, which could stabilize a negatively charged transition state and behave like an oxyanion hole. | [] | The carbonyl oxygen of Asp297, however, is within 3.5 Å of the amide nitrogen of Arg240 and near the side chains of Arg240 and Arg286, which could stabilize a negatively charged transition state and behave like an oxyanion hole. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | After initial
cleavage at Asp297 the peptide chain may be less constrained and
thus free to exit the cavity at the dimer interface, which would allow space
for the adjacent, unprocessed chain to position the second Asp297
near the opposite catalytic cysteine. | [
"21",
"43",
"42",
"44",
"45"
] | 263 | 39,878 | 0 | false | After initial cleavage at Asp297 the peptide chain may be less constrained and thus free to exit the cavity at the dimer interface, which would allow space for the adjacent, unprocessed chain to position the second Asp297 near the opposite catalytic cysteine. | [] | After initial cleavage at Asp297 the peptide chain may be less constrained and thus free to exit the cavity at the dimer interface, which would allow space for the adjacent, unprocessed chain to position the second Asp297 near the opposite catalytic cysteine. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | The higher degree of flexibility
observed in the active-site and Asp297 region
(Fig. | [
"21",
"43",
"42",
"44",
"45"
] | 86 | 39,879 | 0 | false | The higher degree of flexibility observed in the active-site and Asp297 region (Fig. | [] | The higher degree of flexibility observed in the active-site and Asp297 region (Fig. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | 3D) also
suggests flexibility that could accommodate nucleophilic attack of
Asp297 by Cys285 in this region. | [
"21",
"43",
"42",
"44",
"45"
] | 110 | 39,880 | 0 | false | 3D) also suggests flexibility that could accommodate nucleophilic attack of Asp297 by Cys285 in this region. | [] | 3D) also suggests flexibility that could accommodate nucleophilic attack of Asp297 by Cys285 in this region. | false | false | true | true | false | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | Alternatively, it could
be the exclusion of one linker region from the core of the protein that allows
the excluded Asp297 to be processed by yet another zymogen neighbor
by interdimer cleavage. | [
"21",
"43",
"42",
"44",
"45"
] | 197 | 39,881 | 0 | false | Alternatively, it could be the exclusion of one linker region from the core of the protein that allows the excluded Asp297 to be processed by yet another zymogen neighbor by interdimer cleavage. | [] | Alternatively, it could be the exclusion of one linker region from the core of the protein that allows the excluded Asp297 to be processed by yet another zymogen neighbor by interdimer cleavage. | true | true | true | true | true | 6,892 |
0 | DISCUSSION | 1 | 21 | [
"ref21",
"ref43",
"ref42",
"ref44",
"ref45"
] | 19,117,953 | pmid-16682620|NA|pmid-8035875|pmid-12912912|pmid-12399450 | Arguments have been made for both intradimer and
interdimer processing (44,
45), and either scenario would
explain how forced dimerization with an inflammasome could activate the
caspase-1 auto-proteolytic pathway. | [
"21",
"43",
"42",
"44",
"45"
] | 218 | 39,882 | 0 | false | Arguments have been made for both intradimer and interdimer processing, and either scenario would explain how forced dimerization with an inflammasome could activate the caspase-1 auto-proteolytic pathway. | [
"44,\n 45"
] | Arguments have been made for both intradimer and interdimer processing, and either scenario would explain how forced dimerization with an inflammasome could activate the caspase-1 auto-proteolytic pathway. | true | true | true | true | true | 6,892 |
1 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | FIGURE 4.Structural comparison of initiator and effector caspase zymogens. | [
"25"
] | 74 | 39,883 | 0 | false | FIGURE 4.Structural comparison of initiator and effector caspase zymogens. | [] | FIGURE 4.Structural comparison of initiator and effector caspase zymogens. | true | true | true | true | true | 6,893 |
1 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | A, procaspase-1 (PDB code 3E4C) shown as a schematic with the linker
region shown as a thick ribbon. | [
"25"
] | 101 | 39,884 | 0 | false | A, procaspase-1 (PDB code 3E4C) shown as a schematic with the linker region shown as a thick ribbon. | [] | A, procaspase-1 (PDB code 3E4C) shown as a schematic with the linker region shown as a thick ribbon. | true | true | true | true | true | 6,893 |
1 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | Both aspartic acid cleavage sites
between the p20 and p10 in one monomer are shown as spheres. | [
"25"
] | 95 | 39,885 | 0 | false | Both aspartic acid cleavage sites between the p20 and p10 in one monomer are shown as spheres. | [] | Both aspartic acid cleavage sites between the p20 and p10 in one monomer are shown as spheres. | true | true | true | true | true | 6,893 |
1 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | The
dotted line represents unresolved residues not seen in the electron
density maps. | [
"25"
] | 87 | 39,886 | 0 | false | The dotted line represents unresolved residues not seen in the electron density maps. | [] | The dotted line represents unresolved residues not seen in the electron density maps. | true | true | true | true | true | 6,893 |
1 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | B, schematic representation of procaspase-7 (PDB code
1GQF (25)), an effector
caspase, with the interdomain linker shown as a thick ribbon. | [
"25"
] | 141 | 39,887 | 0 | false | B, schematic representation of procaspase-7 ), an effector caspase, with the interdomain linker shown as a thick ribbon. | [
"PDB code\n 1GQF (25"
] | B, schematic representation of procaspase-7 ), an effector caspase, with the interdomain linker shown as a thick ribbon. | true | true | true | true | true | 6,893 |
1 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | Only
the first site of processing in effector caspases is required for activation. | [
"25"
] | 83 | 39,888 | 0 | false | Only the first site of processing in effector caspases is required for activation. | [] | Only the first site of processing in effector caspases is required for activation. | true | true | true | true | true | 6,893 |
1 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | It is noticeable that the first cleavage site is up and away from the dimer
interface in caspase-7. | [
"25"
] | 100 | 39,889 | 0 | false | It is noticeable that the first cleavage site is up and away from the dimer interface in caspase-7. | [] | It is noticeable that the first cleavage site is up and away from the dimer interface in caspase-7. | true | true | true | true | true | 6,893 |
2 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | Structural comparison of initiator and effector caspase zymogens. | [
"25"
] | 65 | 39,890 | 0 | false | Structural comparison of initiator and effector caspase zymogens. | [] | Structural comparison of initiator and effector caspase zymogens. | true | true | true | true | true | 6,894 |
2 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | A, procaspase-1 (PDB code 3E4C) shown as a schematic with the linker
region shown as a thick ribbon. | [
"25"
] | 101 | 39,891 | 0 | false | A, procaspase-1 (PDB code 3E4C) shown as a schematic with the linker region shown as a thick ribbon. | [] | A, procaspase-1 (PDB code 3E4C) shown as a schematic with the linker region shown as a thick ribbon. | true | true | true | true | true | 6,894 |
2 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | Both aspartic acid cleavage sites
between the p20 and p10 in one monomer are shown as spheres. | [
"25"
] | 95 | 39,892 | 0 | false | Both aspartic acid cleavage sites between the p20 and p10 in one monomer are shown as spheres. | [] | Both aspartic acid cleavage sites between the p20 and p10 in one monomer are shown as spheres. | true | true | true | true | true | 6,894 |
2 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | The
dotted line represents unresolved residues not seen in the electron
density maps. | [
"25"
] | 87 | 39,893 | 0 | false | The dotted line represents unresolved residues not seen in the electron density maps. | [] | The dotted line represents unresolved residues not seen in the electron density maps. | true | true | true | true | true | 6,894 |
2 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | B, schematic representation of procaspase-7 (PDB code
1GQF (25)), an effector
caspase, with the interdomain linker shown as a thick ribbon. | [
"25"
] | 141 | 39,894 | 0 | false | B, schematic representation of procaspase-7 ), an effector caspase, with the interdomain linker shown as a thick ribbon. | [
"PDB code\n 1GQF (25"
] | B, schematic representation of procaspase-7 ), an effector caspase, with the interdomain linker shown as a thick ribbon. | true | true | true | true | true | 6,894 |
2 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | Only
the first site of processing in effector caspases is required for activation. | [
"25"
] | 83 | 39,895 | 0 | false | Only the first site of processing in effector caspases is required for activation. | [] | Only the first site of processing in effector caspases is required for activation. | true | true | true | true | true | 6,894 |
2 | DISCUSSION | 1 | 25 | [
"ref25"
] | 19,117,953 | pmid-11752425 | It is noticeable that the first cleavage site is up and away from the dimer
interface in caspase-7. | [
"25"
] | 100 | 39,896 | 0 | false | It is noticeable that the first cleavage site is up and away from the dimer interface in caspase-7. | [] | It is noticeable that the first cleavage site is up and away from the dimer interface in caspase-7. | true | true | true | true | true | 6,894 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | Comparing caspase-1 and caspase-7 zymogens reveals an intriguing
difference, the linkers between the large and small subunits start their
association with the dimer interface at different points
(Fig. | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 203 | 39,897 | 0 | false | Comparing caspase-1 and caspase-7 zymogens reveals an intriguing difference, the linkers between the large and small subunits start their association with the dimer interface at different points (Fig. | [] | Comparing caspase-1 and caspase-7 zymogens reveals an intriguing difference, the linkers between the large and small subunits start their association with the dimer interface at different points (Fig. | true | true | true | true | true | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | 4, A and
B) (24,
25). | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 23 | 39,898 | 0 | false | 4, A and B). | [
"24,\n 25"
] | 4, A and B). | false | false | true | true | false | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | This altered orientation
impacts the location of the first cleavage point in the zymogens. | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 91 | 39,899 | 0 | false | This altered orientation impacts the location of the first cleavage point in the zymogens. | [] | This altered orientation impacts the location of the first cleavage point in the zymogens. | true | true | true | true | true | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | In
caspase-1, the first cleavage site of one monomer is buried in the dimer
interface near the adjacent catalytic cysteine, whereas in caspase-7 this
region is absent from the protein core leaving the first cleavage site
exposed. | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 233 | 39,900 | 0 | false | In caspase-1, the first cleavage site of one monomer is buried in the dimer interface near the adjacent catalytic cysteine, whereas in caspase-7 this region is absent from the protein core leaving the first cleavage site exposed. | [] | In caspase-1, the first cleavage site of one monomer is buried in the dimer interface near the adjacent catalytic cysteine, whereas in caspase-7 this region is absent from the protein core leaving the first cleavage site exposed. | true | true | true | true | true | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | This major difference between an initiator (caspase-1) and an
effector caspase (caspase-7) explains the need for oligomerization to start
the activation process in caspase-1. | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 176 | 39,901 | 0 | false | This major difference between an initiator (caspase-1) and an effector caspase (caspase-7) explains the need for oligomerization to start the activation process in caspase-1. | [] | This major difference between an initiator (caspase-1) and an effector caspase (caspase-7) explains the need for oligomerization to start the activation process in caspase-1. | true | true | true | true | true | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | Effector enzymes, like caspase-7 and
caspase-3, function as downstream components in the proteolytic cascade and do
not contain oligomerization or recruitment domains at the N termini. | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 186 | 39,902 | 0 | false | Effector enzymes, like caspase-7 and caspase-3, function as downstream components in the proteolytic cascade and do not contain oligomerization or recruitment domains at the N termini. | [] | Effector enzymes, like caspase-7 and caspase-3, function as downstream components in the proteolytic cascade and do not contain oligomerization or recruitment domains at the N termini. | true | true | true | true | true | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | Their
zymogens are found dimeric in solution without catalytic activity and are
readily activated by cleavage of the interdomain site by upstream initiators
(such as caspase-8 and caspase-9). | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 194 | 39,903 | 0 | false | Their zymogens are found dimeric in solution without catalytic activity and are readily activated by cleavage of the interdomain site by upstream initiators (such as caspase-8 and caspase-9). | [] | Their zymogens are found dimeric in solution without catalytic activity and are readily activated by cleavage of the interdomain site by upstream initiators (such as caspase-8 and caspase-9). | true | true | true | true | true | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | This is in contrast to caspase-1, and other
initiator caspase zymogens such as caspase-9 and DRONC, which require some
activity as zymogens to autoprocess themselves. | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 168 | 39,904 | 0 | false | This is in contrast to caspase-1, and other initiator caspase zymogens such as caspase-9 and DRONC, which require some activity as zymogens to autoprocess themselves. | [] | This is in contrast to caspase-1, and other initiator caspase zymogens such as caspase-9 and DRONC, which require some activity as zymogens to autoprocess themselves. | true | true | true | true | true | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | Caspase-1, however, apparently
differs from these two initiator caspases as cleavage of the enzyme leads to
large increases in enzyme activity and dimerization. | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 162 | 39,905 | 0 | false | Caspase-1, however, apparently differs from these two initiator caspases as cleavage of the enzyme leads to large increases in enzyme activity and dimerization. | [] | Caspase-1, however, apparently differs from these two initiator caspases as cleavage of the enzyme leads to large increases in enzyme activity and dimerization. | true | true | true | true | true | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | Caspase-9 and DRONC
activation have been shown to be enhanced much more by oligomerization than by
proteolysis (39,
40,
46,
47). | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 133 | 39,906 | 0 | false | Caspase-9 and DRONC activation have been shown to be enhanced much more by oligomerization than by proteolysis. | [
"39,\n 40,\n 46,\n 47"
] | Caspase-9 and DRONC activation have been shown to be enhanced much more by oligomerization than by proteolysis. | true | true | true | true | true | 6,895 |
3 | DISCUSSION | 1 | 24 | [
"ref24",
"ref25",
"ref39",
"ref40",
"ref46",
"ref47"
] | 19,117,953 | pmid-11701129|pmid-11752425|pmid-15941357|pmid-18309328|pmid-16977332|pmid-18084239 | An interpretation of our
combined structural, kinetic, and biochemical data can help explain what is
different about caspase-1 and why both dimerization and proteolysis are
important for activity. | [
"24",
"25",
"39",
"40",
"46",
"47"
] | 199 | 39,907 | 0 | false | An interpretation of our combined structural, kinetic, and biochemical data can help explain what is different about caspase-1 and why both dimerization and proteolysis are important for activity. | [] | An interpretation of our combined structural, kinetic, and biochemical data can help explain what is different about caspase-1 and why both dimerization and proteolysis are important for activity. | true | true | true | true | true | 6,895 |
4 | DISCUSSION | 1 | 35 | [
"ref35",
"ref21",
"ref23"
] | 19,117,953 | pmid-8662843|pmid-16682620|pmid-15314233 | The low level activity of procaspase-1 has previously been recognized in
cell lysates and is characterized kinetically in our report
(Table 1)
(35). | [
"35",
"21",
"23"
] | 151 | 39,908 | 1 | false | The low level activity of procaspase-1 has previously been recognized in cell lysates and is characterized kinetically in our report (Table 1). | [
"35"
] | The low level activity of procaspase-1 has previously been recognized in cell lysates and is characterized kinetically in our report (Table 1). | true | true | true | true | true | 6,896 |
4 | DISCUSSION | 1 | 35 | [
"ref35",
"ref21",
"ref23"
] | 19,117,953 | pmid-8662843|pmid-16682620|pmid-15314233 | One possibility for the
reduced activity of the zymogen could be negative allosteric regulation by the
location of the p20 C terminus. | [
"35",
"21",
"23"
] | 136 | 39,909 | 0 | false | One possibility for the reduced activity of the zymogen could be negative allosteric regulation by the location of the p20 C terminus. | [] | One possibility for the reduced activity of the zymogen could be negative allosteric regulation by the location of the p20 C terminus. | true | true | true | true | true | 6,896 |
4 | DISCUSSION | 1 | 35 | [
"ref35",
"ref21",
"ref23"
] | 19,117,953 | pmid-8662843|pmid-16682620|pmid-15314233 | An allosteric regulatory site in this region
has previously been characterized in both caspase-1 and caspase-7
(21,
23). | [
"35",
"21",
"23"
] | 123 | 39,910 | 0 | false | An allosteric regulatory site in this region has previously been characterized in both caspase-1 and caspase-7. | [
"21,\n 23"
] | An allosteric regulatory site in this region has previously been characterized in both caspase-1 and caspase-7. | true | true | true | true | true | 6,896 |
4 | DISCUSSION | 1 | 35 | [
"ref35",
"ref21",
"ref23"
] | 19,117,953 | pmid-8662843|pmid-16682620|pmid-15314233 | The tryptophan and
phenylalanine that bind in this region occupy a position similar to small
molecule-allosteric inhibitors (Fig. | [
"35",
"21",
"23"
] | 131 | 39,911 | 0 | false | The tryptophan and phenylalanine that bind in this region occupy a position similar to small molecule-allosteric inhibitors (Fig. | [] | The tryptophan and phenylalanine that bind in this region occupy a position similar to small molecule-allosteric inhibitors (Fig. | true | true | true | true | true | 6,896 |
4 | DISCUSSION | 1 | 35 | [
"ref35",
"ref21",
"ref23"
] | 19,117,953 | pmid-8662843|pmid-16682620|pmid-15314233 | However, despite the conserved positioning, the
small molecules are more potent because they completely inactivate the enzyme. | [
"35",
"21",
"23"
] | 127 | 39,912 | 0 | false | However, despite the conserved positioning, the small molecules are more potent because they completely inactivate the enzyme. | [] | However, despite the conserved positioning, the small molecules are more potent because they completely inactivate the enzyme. | true | true | true | true | true | 6,896 |
4 | DISCUSSION | 1 | 35 | [
"ref35",
"ref21",
"ref23"
] | 19,117,953 | pmid-8662843|pmid-16682620|pmid-15314233 | This may be due to the covalent bond between the small molecules and
Cys331. | [
"35",
"21",
"23"
] | 77 | 39,913 | 0 | false | This may be due to the covalent bond between the small molecules and Cys331. | [] | This may be due to the covalent bond between the small molecules and Cys331. | true | true | true | true | true | 6,896 |
4 | DISCUSSION | 1 | 35 | [
"ref35",
"ref21",
"ref23"
] | 19,117,953 | pmid-8662843|pmid-16682620|pmid-15314233 | The added effect of this bond could be to completely block
protein rearrangement in this region that occurs during substrate binding (see
substrate-bound state in Fig. | [
"35",
"21",
"23"
] | 169 | 39,914 | 0 | false | The added effect of this bond could be to completely block protein rearrangement in this region that occurs during substrate binding (see substrate-bound state in Fig. | [] | The added effect of this bond could be to completely block protein rearrangement in this region that occurs during substrate binding (see substrate-bound state in Fig. | true | true | true | true | true | 6,896 |
4 | DISCUSSION | 1 | 35 | [
"ref35",
"ref21",
"ref23"
] | 19,117,953 | pmid-8662843|pmid-16682620|pmid-15314233 | The p20 C terminus, when bound at this site, is
likely to be more flexible during active-site binding. | [
"35",
"21",
"23"
] | 103 | 39,915 | 0 | false | The p20 C terminus, when bound at this site, is likely to be more flexible during active-site binding. | [] | The p20 C terminus, when bound at this site, is likely to be more flexible during active-site binding. | true | true | true | true | true | 6,896 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.